Neuca

Neuca FCF per Share

The Free Cash Flow per Share of Neuca (NEU.WA) as of Oct 21, 2026 is 79.16 PLN. In the previous year, Free Cash Flow per Share was -6.55 PLN — a change of -1,307.97% (higher).

FCF per Share

79.16PLN

YoY

-1,307.97%

Last updated:

Free Cash Flow per Share of Neuca is 2025 79.16 PLN. Free Cash Flow per Share of Neuca was 2024 -6.55 PLN. It decreases by -1,307.97% higher compared to the previous year.

The Neuca FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
2.65 PLN
Jan 1, 2019
19.13 PLN
Jan 1, 2020
54.86 PLN
Jan 1, 2021
53.40 PLN
Jan 1, 2022
56.81 PLN
Jan 1, 2023
42.85 PLN
Jan 1, 2024
-6.55 PLN
Jan 1, 2025
79.16 PLN
The Neuca FCF per Share history
YEARFCF per ShareYoY
79.16PLN-1,307.97%
-6.55PLN-115.29%
42.85PLN-24.57%
56.81PLN+6.38%
53.40PLN-2.65%
54.86PLN+186.72%
19.13PLN+622.96%
2.65PLN-80.44%
13.53PLN-54.17%
29.52PLN-12.15%
33.61PLN-8.64%
36.78PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neuca Stock analysis

What does Neuca do? NEUCA SA generates revenue through the wholesale distribution of pharmaceutical products to pharmacies, leveraging its extensive network in the health market. The company also produces and sells its own branded drugs, supplements, and cosmetics, while offering clinical trials, telemedicine services, and IT solutions tailored for healthcare providers. Its e-commerce platform further supports the healthcare industry by enabling digital transactions for medical products and services. The primary buyers include pharmacies, healthcare institutions, and consumers seeking health-related products through online channels. NEUCA SA's business model integrates multiple revenue streams within the health sector, with a focus on both physical and digital distribution. The firm's own-brand products, such as pharmaceuticals and cosmetics, are sold directly to end-users and retail partners, while its IT solutions and telemedicine services target healthcare organizations. Clinical trials represent another key segment, attracting partnerships with research institutions and pharmaceutical firms. The company's operational scope spans from production to distribution, ensuring a comprehensive approach to healthcare market needs. The company's revenue is driven by its diversified portfolio, including drug distribution, branded product sales, and specialized services like telemedicine and clinical trials. Pharmacies remain the core customer segment for its wholesale operations, while e-commerce and IT solutions cater to a broader audience of healthcare providers and consumers. NEUCA SA's strategic positioning in the health market allows it to capitalize on multiple growth areas without relying on a single revenue source. Neuca is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neuca stock

Free Cash Flow per Share of Neuca is 79.16 PLN in 2025.

Free Cash Flow per Share of Neuca changed from -6.55 PLN to 79.16 PLN, representing a -1,307.97% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Neuca since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Neuca

All Key Metrics — Neuca